HI Stock Overview
Health Italia S.p.A. promotes supplementary health plans and solutions for the prevention and well-being of the families, SMEs, corporates, and public administration in Italy. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Health Italia S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €136.50 |
52 Week High | €175.00 |
52 Week Low | €87.20 |
Beta | 0.023 |
1 Month Change | 6.64% |
3 Month Change | 31.25% |
1 Year Change | 10.98% |
3 Year Change | -9.00% |
5 Year Change | -65.79% |
Change since IPO | -63.74% |
Recent News & Updates
Subdued Growth No Barrier To Health Italia S.p.A. (BIT:HI) With Shares Advancing 35%
Oct 10Investors Can Find Comfort In Health Italia's (BIT:HI) Earnings Quality
Sep 29Returns Are Gaining Momentum At Health Italia (BIT:HI)
Jul 22Recent updates
Subdued Growth No Barrier To Health Italia S.p.A. (BIT:HI) With Shares Advancing 35%
Oct 10Investors Can Find Comfort In Health Italia's (BIT:HI) Earnings Quality
Sep 29Returns Are Gaining Momentum At Health Italia (BIT:HI)
Jul 22Health Italia's (BIT:HI) Soft Earnings Don't Show The Whole Picture
Mar 17Lacklustre Performance Is Driving Health Italia S.p.A.'s (BIT:HI) Low P/E
Jan 25Returns Are Gaining Momentum At Health Italia (BIT:HI)
Nov 25Health Italia (BIT:HI) Has A Pretty Healthy Balance Sheet
Oct 21Health Italia (BIT:HI) Shareholders Will Want The ROCE Trajectory To Continue
Aug 07These 4 Measures Indicate That Health Italia (BIT:HI) Is Using Debt Reasonably Well
May 13Returns On Capital At Health Italia (BIT:HI) Have Stalled
Dec 30Here's Why Health Italia (BIT:HI) Can Manage Its Debt Responsibly
Nov 10Be Wary Of Health Italia (BIT:HI) And Its Returns On Capital
Jun 23We Think Health Italia (BIT:HI) Can Stay On Top Of Its Debt
May 27Investors Could Be Concerned With Health Italia's (BIT:HI) Returns On Capital
Feb 23Health Italia (BIT:HI) Seems To Use Debt Quite Sensibly
Dec 08Health Italia (BIT:HI) Will Want To Turn Around Its Return Trends
Oct 06Health Italia (BIT:HI) Will Will Want To Turn Around Its Return Trends
Mar 22Is Health Italia S.p.A. (BIT:HI) A Good Dividend Stock?
Jan 28We're Watching These Trends At Health Italia (BIT:HI)
Dec 04Shareholder Returns
HI | IT Healthcare | IT Market | |
---|---|---|---|
7D | 3.8% | -2.0% | -2.8% |
1Y | 11.0% | 1.9% | 8.5% |
Return vs Industry: HI exceeded the Italian Healthcare industry which returned 1.9% over the past year.
Return vs Market: HI exceeded the Italian Market which returned 8.5% over the past year.
Price Volatility
HI volatility | |
---|---|
HI Average Weekly Movement | 11.8% |
Healthcare Industry Average Movement | 4.2% |
Market Average Movement | 4.3% |
10% most volatile stocks in IT Market | 7.8% |
10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: HI's share price has been volatile over the past 3 months compared to the Italian market.
Volatility Over Time: HI's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 101 | Livia Foglia | www.healthitalia.it |
Health Italia S.p.A. promotes supplementary health plans and solutions for the prevention and well-being of the families, SMEs, corporates, and public administration in Italy. The company offers integrative health solutions; telemedicine services; and food supplements, medical devices, and cosmeceutical products. The company was formerly known as Health Holding Group S.p.A. and changed its name to Health Italia S.p.A. in 2015.
Health Italia S.p.A. Fundamentals Summary
HI fundamental statistics | |
---|---|
Market cap | €25.52m |
Earnings (TTM) | €1.69m |
Revenue (TTM) | €37.48m |
15.1x
P/E Ratio0.7x
P/S RatioIs HI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HI income statement (TTM) | |
---|---|
Revenue | €37.48m |
Cost of Revenue | €29.26m |
Gross Profit | €8.21m |
Other Expenses | €6.53m |
Earnings | €1.69m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 9.02 |
Gross Margin | 21.92% |
Net Profit Margin | 4.50% |
Debt/Equity Ratio | 21.3% |
How did HI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:46 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Health Italia S.p.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Luigi Tardella | EnVent Capital Markets Limited |
Matthias Greiffenberger | GBC AG |